VAERS ID: 1235666

AGE: | SEX: M|STATE: GA (United States)

Description

Patient got scared and did not get his second dose; tried to urinate and could not; passed a clot with some drops of blood; This spontaneous case was reported by a consumer and describes the occurrence of URINARY RETENTION (tried to urinate and could not) and HAEMORRHAGE URINARY TRACT (passed a clot with some drops of blood) in a 73-year-old male patient who received mRNA-1273 (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Tumor (Malignancy in the tubular tumor in Penis) and Bladder operation (in past 3 months). Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN, LISINOPRIL, AMLODIPINE and ESCITALOPRAM for an unknown indication, PRAVASTATIN SODIUM (PRAVASTATIN NA). On 16-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced URINARY RETENTION (tried to urinate and could not) (seriousness criterion medically significant) and HAEMORRHAGE URINARY TRACT (passed a clot with some drops of blood) (seriousness criterion medically significant). On 13-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient got scared and did not get his second dose). At the time of the report, URINARY RETENTION (tried to urinate and could not), HAEMORRHAGE URINARY TRACT (passed a clot with some drops of blood) and PRODUCT DOSE OMISSION ISSUE (Patient got scared and did not get his second dose) outcome was unknown. The action taken with mRNA-1273 (Intramuscular) was unknown. Treatment medication was not reported. Based on the current available information and the temporal association between the product use and the start of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start of the events a causal relationship cannot be excluded.

Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)

Symptoms

Urinary retention, Haemorrhage urinary tract, Product dose omission issue

Vaccines

VAX DATE: 03-16-2021| ONSET DATE: 03-31-2021| DAYS TO ONSET: 15
NameDose #TypeManufacturerLotRouteSite
COVID19 (COVID19 (MODERNA)) 1 COVID19 MODERNA 024M20A OT Unknown

RECVDATE:04-21-2021
RPT_DATE:
CAGE_YR:
CAGE_MO:
DIED:U
DATEDIED:
L_THREAT:U
ER_VISIT:
HOSPITAL:U
HOSPDAYS:
X_STAY:U
DISABLE:U
RECOVD:U
LAB_DATA:
V_ADMINBY:
OTHER_MEDS:METFORMIN; LISINOPRIL; AMLODIPINE; ESCITALOPRAM; PRAVASTATIN NA
CUR_ILL:Diabetes; Hypertension
HISTORY:Medical History/Concurrent Conditions: Bladder operation (in past 3 months); Tumor (Malignancy in the tubular tumor in Penis)
PRIOR_VAX:
SPLTTYPE:USMODERNATX, INC.MOD20210
FORM_VERS:
TODAYS_DATE:04-20-2021
BIRTH_DEFECT:U
OFC_VISIT:U
ER_ED_VISIT:U
ALLERGIES:
V_FUNDBY:

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.